Literature DB >> 9076340

Signal transduction mechanism of insulin and insulin-like growth factor-1.

T Kadowaki1, K Tobe, R Honda-Yamamoto, H Tamemoto, Y Kaburagi, K Momomura, K Ueki, Y Takahashi, T Yamauchi, Y Akanuma, Y Yazaki.   

Abstract

Insulin and insulin-like growth factor-1 (IGF-1) are two structurally related hormones which produce similar biological activities such as metabolic and growth promoting actions. Their receptors, insulin and IGF-1 receptors, also share similarities in both structure and functions such as tyrosine-specific protein kinase. We identified insulin receptor substrate-1 (IRS-1) as a common substrate for insulin and IGF-1 receptor tyrosine kinases. We generated IRS-1 knockout mice and showed that IRS-1 plays a physiological role in signal transduction and biological actions of insulin and IGF-1. We also identified pp190 (IRS-2) as an alternative substrate for IRS-1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9076340     DOI: 10.1507/endocrj.43.suppl_s33

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  23 in total

1.  Intracerebroventricular insulin-like growth factor-1 decreases feeding in diabetic rats.

Authors:  H Lu; B Martinez-Nieves; K Lapanowski; J Dunbar
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

2.  Akt promotes BMP2-mediated osteoblast differentiation and bone development.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  J Cell Sci       Date:  2009-02-10       Impact factor: 5.285

3.  Association between serum leptin and bone metabolic markers, and the development of heterotopic ossification of the spinal ligament in female patients with ossification of the posterior longitudinal ligament.

Authors:  Yoshikazu Ikeda; Arata Nakajima; Atsuomi Aiba; Masao Koda; Akihiko Okawa; Kazuhisa Takahashi; Masashi Yamazaki
Journal:  Eur Spine J       Date:  2011-01-22       Impact factor: 3.134

4.  Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover.

Authors:  N Ogata; D Chikazu; N Kubota; Y Terauchi; K Tobe; Y Azuma; T Ohta; T Kadowaki; K Nakamura; H Kawaguchi
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 5.  Vascular signaling pathways in the metabolic syndrome.

Authors:  Hiromi Rakugi; Kei Kamide; Toshio Ogihara
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 6.  Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.

Authors:  Christopher A Chapleau; Jane Lane; Lucas Pozzo-Miller; Alan K Percy
Journal:  Curr Clin Pharmacol       Date:  2013-11

7.  Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.

Authors:  S P Cousin; S R Hügl; M G Myers; M F White; A Reifel-Miller; C J Rhodes
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

8.  Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors.

Authors:  R R Flörke; K Schnaith; W Passlack; M Wichert; L Kuehn; M Fabry; M Federwisch; H Reinauer
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

9.  The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway.

Authors:  Betty Lamothe; Masashi Yamada; Ute Schaeper; Walter Birchmeier; Irit Lax; Joseph Schlessinger
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 10.  Skeletal effects of growth hormone and insulin-like growth factor-I therapy.

Authors:  Richard C Lindsey; Subburaman Mohan
Journal:  Mol Cell Endocrinol       Date:  2015-09-25       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.